The EASL Studio is back! Join experts Debbie Shawcross, Cynthia Levy, Stephen Rossi, and Michael Trauner this Wednesday 18:00 CET to learn more about endpoints, safety, and where they might fit in the care pathway for PSC patients. Read more: https://lnkd.in/eXSWG6c4
EASL | The Home of Hepatology
Gemeinnützige Organisationen
Geneva, Geneva 12.928 Follower:innen
Beating liver disease
Info
EASL, the European Association for the Study of the Liver, founded in 1966, is a medical association dedicated to pursuing excellence in liver research, to the clinical practice of liver disorders, and to providing education to all those interested in hepatology. As of 2022, EASL serves 4,800 members. EASL engages globally with all stakeholders in the field of hepatology, worldwide. Our aim is to spread knowledge and expertise in best practices and the latest scientific breakthroughs in this field. We advocate for the benefit of patients and advise European and national health authorities. EASL runs topical conferences, schools, and related educational meetings. Our journals, the Journal of Hepatology and JHEP Reports, provide an international forum for the publication of original articles, reviews, and letters to the Editor, describing the latest science in hepatology. Our eLearning hub, EASL Campus, offers more than 6,200 resources on hepatology and liver research.
- Website
 - 
        
                  
    
      https://easl.eu/
      
    
  
                  
Externer Link zu EASL | The Home of Hepatology
 - Branche
 - Gemeinnützige Organisationen
 - Größe
 - 11–50 Beschäftigte
 - Hauptsitz
 - Geneva, Geneva
 - Art
 - Nonprofit
 - Gegründet
 - 1966
 - Spezialgebiete
 - Hepatology
 
Orte
- 
                  
                    Primär
                  
                Wegbeschreibung
Rue Daubin 7
Geneva, Geneva 1203, CH
 
Beschäftigte von EASL | The Home of Hepatology
- 
              
    
    
    
    
    
      
        
      
          
      
Pedro Miguel Baptista
Group Leader @ Instituto de Investigación Sanitaria Aragón | Co-Founder, EASL Consortium for Regenerative Hepatology
 - 
              
    
    
    
    
    
      
        
      
          
      
Celine SANTO
Events Coordinator
 - 
              
    
    
    
    
    
      
        
      
          
      
Debbie Shawcross
Professor of Hepatology & Chronic Liver Failure, Roger Williams Institute of Liver Studies, King's College London, Foundation for Liver Research &…
 - 
              
    
    
    
    
    
      
        
      
          
      
Marina Triantafyllou
General Manager at Sithonia Lodge Holiday Homes
 
Updates
- 
              
        
    
⏰ Final call for abstracts! 🚨 The EASL #SLDSummit Abstract submission closes tomorrow, 4 November! 👉Present your work to an international audience of experts, gain visibility within the liver community, and inspire new collaborations! 📜Don't miss your chance - submit now: https://lnkd.in/eJWcTXdR William Alazawi Anna Alisi Ramon Bataller CYRIELLE CAUSSY Debbie Shawcross Ana Lleo
 - 
                  
 - 
              
        
    
What’s the difference between acute decompensation and ACLF? In this short video, Prof. Paolo Angeli explains how understanding these two conditions can transform patient care. 🎥 Watch the full #EASLStudio episode on demand to hear the expert discussion: https://lnkd.in/eW-b7C-9 Thomas Marjot Debbie Shawcross Ana Lleo
 - 
              
        
    
Today’s #readoftheweek📚 highlights the need for more inclusive research and calls attention to potential sex-specific prognostic factors in liver transplantation for colorectal liver metastases. Read here this JHEP Reports article: https://lnkd.in/exkT7zhn 🙏 to authors Alessandro Vitale, Jacopo Lanari, Umberto Cillo, Ilaria Billato, Alessandro Rovetta, Mohammad Ali Mansournia, Matteo Cescon, Matteo Serenari, Federico Aucejo, Bassam Estfan, Laurent Coubeau, Samuele Iesari, Vincenzo Mazzaferro, Carlo Sposito, Roberto Hernandez-Alejandro, Koji Tomiyama, Morten Hagness, Svein Dueland, and Pål-Dag Line. Università degli Studi di Padova Oslo University Hospital
 - 
                  
 - 
              
        
    
#SteatoticLiverDisease is increasingly recognised as a multisystem disease. This session will highlight new findings on immunological networks in #MASLD, metabolomic models of organ cross-talk, and the gut–brain–liver axis in #ALD. Together, these perspectives underline the systemic nature of SLD and point to unveil novel intervention outputs. 🤔Curious to find out more? Attend the EASL #SLDSummit on 26-28 February in Budapest! 👉Early fees available until 18 November: https://lnkd.in/ezmH4rYF Ramon Bataller William Alazawi Anna Alisi CYRIELLE CAUSSY Debbie Shawcross Ana Lleo
 - 
                  
 - 
              
        
    
📜 Only a few days left for you to finalise and submit your abstract to EASL #SLDSummit, taking place in Budapest on 26-28 February 2026! ⏰Deadline: 4 November 💡This is your opportunity to showcase your latest findings, gain international visibility, and contribute to advancing understanding and management of steatotic liver disease. 👉Submit now: https://lnkd.in/eJWcTXdR Debbie Shawcross Ana Lleo CYRIELLE CAUSSY William Alazawi Ramon Bataller Anna Alisi
 - 
                  
 - 
              
        
    
You can still register for tonight's EASL Genetic Grand Round on the many faces of MDR3! 🗓️ Wednesday, 29 October, 18:00 CET 🔗 https://lnkd.in/e49bHCcQ
 - 
                  
 - 
              
        
    
⏰Have you secured your spot at the EASL #LiverCancerSummit? TODAY, 28 October is the last day to do so with advantageous early fees. Discover a scientific programme tailored to your interests, numerous possibilities for networking, and the most current updates in liver tumour research and care. 👉Join us in Edinburgh on 22-24 January! https://lnkd.in/e5WUFsgr Debbie Shawcross Ana Lleo David James Pinato Josep M Llovet Irene Bargellini
 - 
                  
 - 
              
        
    
🍷 To mark the final week of Breast Cancer Awareness Month, over 20 health groups have come together with one clear message for policymakers: it’s time to take stronger action against alcohol. In a joint statement, the European Health Alliance on Alcohol (EHAA) - a coalition of experts and organisations working to reduce the burden of alcohol-related harm across Europe – is calling on EU and national policymakers to introduce mandatory health warnings on alcoholic beverages. Why? Because these warnings are essential to better inform people about the proven link between alcohol and cancer. 💬 “Alcohol increases breast cancer risk, even in small amounts. This Breast Cancer Awareness Month, we call on the European Commission and EU member states to follow the WHO’s recommendations, dispel the dangerous myth that only heavy drinkers are affected, and to introduce science-based policies that ensure people know what is hidden in their glass,” explains Alba Gil, Policy Officer at the Association of European Cancer Leagues (ECL). 👉 Read the full press release: https://lnkd.in/eZ4K5gN4 ESMO - European Society for Medical Oncology WHO Regional Office for Europe European Cancer Organisation
 - 
                  
 - 
              
        
    
3 weeks left to send your application or nomination for the EASL Awards 2026! 🏆Community Award – Recognising significant contributions in hepatology, including teaching, advocacy, and innovation. 🏆Emerging Leader Award – Celebrating young researchers with outstanding liver research achievements. 🏆Excellence in Liver Care Award – Honoring emerging talents in liver care and service excellence. Read more and apply by 18 November: https://lnkd.in/enR3SxzK
 -